Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Pinshangpin Pharmaceutical Technology is a China-based pharmaceutical company specializing in the research, development, and technical service of high-end generic drugs and innovative small molecule therapeutics. The company operates primarily as a Contract Research Organization (CRO) and technology provider, offering comprehensive services including drug synthesis, formulation development, and quality control standards. Their portfolio focuses on therapeutic areas such as cardiovascular health, metabolic diseases, and anti-infectives, aiming to improve drug accessibility through high-quality pharmaceutical engineering. Beijing Pinshangpin is recognized for its expertise in navigating the Chinese regulatory landscape and providing technical transfer services to domestic manufacturing partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Pinshangpin Pharmaceutical Technology.